niacinamide has been researched along with Dyslipidemias in 8 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperphosphatemia is thought to be a central-risk factor for CKD-MBD." | 1.42 | Niacin and Chronic Kidney Disease. ( Masuda, M; Miyamoto, K; Segawa, H; Takeda, E; Taketani, Y; Tatsumi, S; Yamamoto, H; Yamanaka-Okumura, H, 2015) |
| "The disturbance of lipid metabolism was induced by the introduction of exogenic cholesterol-in -oil emulsion in dosage 40 mg /kg of body mass during 20 days." | 1.40 | [The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia]. ( Antropova, NV; Kustikova, IN; Moiseeva, IIa; Rodina, OP; Vodop'ianova, OA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Verma, H | 1 |
| Garg, R | 1 |
| Olatunji, OJ | 1 |
| Chen, H | 1 |
| Zhou, Y | 1 |
| Vodop'ianova, OA | 2 |
| Moiseeva, IIa | 2 |
| Rodina, OP | 2 |
| Kustikova, IN | 2 |
| Antropova, NV | 2 |
| Taketani, Y | 1 |
| Masuda, M | 1 |
| Yamanaka-Okumura, H | 1 |
| Tatsumi, S | 1 |
| Segawa, H | 1 |
| Miyamoto, K | 1 |
| Takeda, E | 1 |
| Yamamoto, H | 1 |
| Perez-Gutierrez, RM | 1 |
| Damian-Guzman, M | 1 |
| Ferreira, MR | 1 |
| Camberos, Mdel C | 1 |
| Selenscig, D | 1 |
| Martucci, LC | 1 |
| Chicco, A | 1 |
| Lombardo, YB | 1 |
| Cresto, JC | 1 |
| Bogan, KL | 1 |
| Brenner, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Validation of an Enzymatic Assay for Quantification of Nicotinamide Adenine Dinucleotide in Blood Plasma After Ingestion of the Vitamin B3 Variant Nicotinamide Riboside: a Randomized Controlled Trial[NCT06005350] | 54 participants (Anticipated) | Interventional | 2023-11-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for niacinamide and Dyslipidemias
| Article | Year |
|---|---|
Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition.
Topics: Animals; Caloric Restriction; Candida glabrata; Dietary Supplements; Dyslipidemias; Humans; NAD; Nia | 2008 |
7 other studies available for niacinamide and Dyslipidemias
| Article | Year |
|---|---|
Evaluation of synergistic combination comprising magnesium orotate, menaquinone-7, and cholecalciferol for management of type 2 diabetes and dyslipidemia.
Topics: Animals; Cholecalciferol; Diabetes Mellitus, Experimental; Disease Models, Animal; Dyslipidemias; Hy | 2020 |
Effect of the Polyphenol Rich Ethyl Acetate Fraction from the Leaves of Lycium chinenseMill. on Oxidative Stress, Dyslipidemia, and Diabetes Mellitus in Streptozotocin-Nicotinamide Induced Diabetic Rats.
Topics: Acetates; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dyslipidemias; Lyciu | 2017 |
[The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia].
Topics: Animals; Animals, Outbred Strains; Antioxidants; Catalase; Drug Combinations; Dyslipidemias; Erythro | 2014 |
[The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
Topics: Animals; Anxiety; Disease Models, Animal; Drug Combinations; Dyslipidemias; Emotions; Flavin Mononuc | 2014 |
Niacin and Chronic Kidney Disease.
Topics: Biological Transport; Bone Diseases; Cardiovascular Diseases; Dyslipidemias; Humans; Hyperphosphatem | 2015 |
Meliacinolin: a potent α-glucosidase and α-amylase inhibitor isolated from Azadirachta indica leaves and in vivo antidiabetic property in streptozotocin-nicotinamide-induced type 2 diabetes in mice.
Topics: alpha-Amylases; Animals; Azadirachta; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Di | 2012 |
Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-L-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats.
Topics: Acetyl-CoA Carboxylase; Acetylcarnitine; Animals; Body Weight; Carnitine O-Palmitoyltransferase; Dis | 2013 |